Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL)
1 clinical trials · Condition
◉ Watch Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL)
| Record | Firm | Date |
|---|---|---|
| A Study of TQ-B3101 in Subjects With Relapsed or Refractory Anaplastic Large Cell Lymphoma (ALCL) (NCT04306887) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2019-11-29 |
Track Relapsed/Refractory Anaplastic Large Cell Lymphoma (ALCL) automatically
Every clearance here is in the API, with alerts when new ones post.